Literature DB >> 1592449

Salt-dependency of endothelin-induced, chronic hypertension in conscious rats.

L H Mortensen1, G D Fink.   

Abstract

The effect of salt intake on the hypertensive response to long-term infusion of endothelin-1 was investigated. Chronically instrumented male Sprague-Dawley rats (325-375 g) were used in a 15-day protocol that included 3 control days followed by 7 days of endothelin-1 infusion at 5.0 pmol.kg-1.min-1 and 5 days of recovery. Rats were maintained on either a normal sodium chloride intake (2.0 meq Na+ per day; normal sodium) or a high sodium chloride intake (6.0 meq Na+ per day; high sodium) throughout the protocol. Control rats received normal or high sodium intakes but not endothelin-1. In high-sodium rats, endothelin-1 produced a significant increase in mean arterial pressure and total peripheral resistance; a significant bradycardia was observed only on the first day after the start of the endothelin-1 infusion. Cardiac output, stroke volume, water balance, and urinary sodium and potassium excretion remained unchanged. Termination of endothelin-1 infusion resulted in rapid normalization of both arterial pressure and peripheral resistance. In contrast, normal sodium rats exhibited no alteration in mean arterial pressure, heart rate, total peripheral resistance, stroke volume, water balance, or urinary sodium and potassium excretion throughout the endothelin-1 infusion protocol. The hypertension produced by endothelin-1 infusion cannot be explained by alterations in salt or water balance since endothelin-1 infusion in high sodium animals produced significant increases in mean arterial pressure with no observable changes in water or electrolyte balance. These results indicate that endothelin-induced hypertension in conscious rats is a salt-dependent model of hypertension.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1592449     DOI: 10.1161/01.hyp.19.6.549

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

Review 1.  Physiology of endothelin and the kidney.

Authors:  Donald E Kohan; Edward W Inscho; Donald Wesson; David M Pollock
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

Review 2.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

Review 3.  Role of endothelin in hypertension.

Authors:  B K Krämer; M Ackermann; S M Kohler; G A Riegger
Journal:  Clin Investig       Date:  1994-01

4.  Dissecting the complex physiology of endothelin: new lessons from genetic models.

Authors:  David M Pollock
Journal:  Hypertension       Date:  2010-06-01       Impact factor: 10.190

5.  Renal denervation attenuates hypertension but not salt sensitivity in ETB receptor-deficient rats.

Authors:  Bryan K Becker; Amanda C Feagans; Daian Chen; Malgorzata Kasztan; Chunhua Jin; Joshua S Speed; Jennifer S Pollock; David M Pollock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-07-12       Impact factor: 3.619

6.  Interleukin-1beta, but not interleukin-6, enhances renal and systemic endothelin production in vivo.

Authors:  Erika I Boesen; Jennifer M Sasser; Mohamed A Saleh; William A Potter; Mandy Woods; Timothy D Warner; Jennifer S Pollock; David M Pollock
Journal:  Am J Physiol Renal Physiol       Date:  2008-06-04

Review 7.  Endothelin.

Authors:  Anthony P Davenport; Kelly A Hyndman; Neeraj Dhaun; Christopher Southan; Donald E Kohan; Jennifer S Pollock; David M Pollock; David J Webb; Janet J Maguire
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

Review 8.  Endothelin antagonism and its role in the treatment of hypertension.

Authors:  Rebecca C Moorhouse; David J Webb; David C Kluth; Neeraj Dhaun
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.